XMME.DE vs. XGEN.DE
XMME.DE (Xtrackers MSCI Emerging Markets UCITS ETF 1C) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both exchange-traded funds - XMME.DE is a Emerging Markets Equities fund tracking the MSCI Emerging Markets, while XGEN.DE is a Health & Biotech Equities fund tracking the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, XMME.DE returned 21.36%/yr vs 1.39%/yr for XGEN.DE. At a 0.44 correlation, their price movements are largely independent. XMME.DE charges 0.18%/yr vs 0.30%/yr for XGEN.DE.
Performance
XMME.DE vs. XGEN.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XMME.DE achieves a 30.06% return, which is significantly higher than XGEN.DE's -1.40% return.
XMME.DE
- 1D
- -1.04%
- 1M
- 7.79%
- YTD
- 30.06%
- 6M
- 31.13%
- 1Y
- 51.93%
- 3Y*
- 21.36%
- 5Y*
- 8.66%
- 10Y*
- —
XGEN.DE
- 1D
- 3.92%
- 1M
- 6.45%
- YTD
- -1.40%
- 6M
- -3.78%
- 1Y
- 22.37%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
XMME.DE vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XMME.DE Xtrackers MSCI Emerging Markets UCITS ETF 1C | 30.06% | 18.69% | 13.82% | 5.89% | -6.02% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
Correlation
The correlation between XMME.DE and XGEN.DE is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.39 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.44 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XMME.DE vs. XGEN.DE — Risk / Return Rank
XMME.DE
XGEN.DE
XMME.DE vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Emerging Markets UCITS ETF 1C (XMME.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XMME.DE | XGEN.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.78 | ||
| Sortino ratioReturn per unit of downside risk | +2.11 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.21 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 4.98 | 1.49 | +3.49 |
| Martin ratioReturn relative to average drawdown | 18.04 | 3.61 | +14.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XMME.DE | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.00 | 1.23 | +1.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | -0.11 | +0.55 |
Drawdowns
XMME.DE vs. XGEN.DE - Drawdown Comparison
The maximum XMME.DE drawdown since its inception was -31.96%, smaller than the maximum XGEN.DE drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for XMME.DE and XGEN.DE.
Loading charts...
Drawdown Indicators
| XMME.DE | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -31.96% | -37.58% | +5.62% |
Max Drawdown (1Y)Largest decline over 1 year | -10.67% | -14.99% | +4.32% |
Max Drawdown (3Y)Largest decline over 3 years | -19.16% | -28.21% | +9.05% |
Max Drawdown (5Y)Largest decline over 5 years | -24.38% | — | — |
Current DrawdownCurrent decline from peak | -1.04% | -14.86% | +13.82% |
Average DrawdownAverage peak-to-trough decline | -9.53% | -19.44% | +9.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.95% | 6.19% | -3.24% |
Volatility
XMME.DE vs. XGEN.DE - Volatility Comparison
Xtrackers MSCI Emerging Markets UCITS ETF 1C (XMME.DE) has a higher volatility of 7.48% compared to Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) at 6.48%. This indicates that XMME.DE's price experiences larger fluctuations and is considered to be riskier than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XMME.DE | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.48% | 6.48% | +1.00% |
Volatility (6M)Calculated over the trailing 6-month period | 14.90% | 13.73% | +1.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.70% | 18.19% | -0.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.74% | 18.66% | -1.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.61% | 18.66% | -0.05% |
XMME.DE vs. XGEN.DE - Expense Ratio Comparison
XMME.DE has a 0.18% expense ratio, which is lower than XGEN.DE's 0.30% expense ratio.
Dividends
XMME.DE vs. XGEN.DE - Dividend Comparison
Neither XMME.DE nor XGEN.DE has paid dividends to shareholders.
Frequently Asked Questions
XMME.DE and XGEN.DE have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XMME.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XMME.DE is cheaper with a 0.18% expense ratio, compared with 0.30% for XGEN.DE.
XMME.DE is categorized as Emerging Markets Equities, while XGEN.DE is Health & Biotech Equities. XMME.DE tracks MSCI Emerging Markets, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Their fees differ too: 0.18% for XMME.DE and 0.30% for XGEN.DE.
Find the right allocation for XMME.DE and XGEN.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer